Search Results

Site Search

Laboratory Innovation: Dr. Bill Morice - Insights

This week on "Answers From the Lab," William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his...

Predictions for 2023: Dr. Bill Morice - Insights

William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins “Answers From the Lab” for his weekly leadership update with host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo...

Viruses and Variants: Dr. Bill Morice - Insights

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update with Bobbi...

CPT codes and LOINC update: December 2021 - Insights

CPT code updates posted to mayocliniclabs.com during the month of December.

Mayo Clinic Laboratory and pathology research roundup: September 27 - Insights

This week's research roundup features: Robotics in neurosurgery: current prevalence and future directions

Mayo Clinic Laboratory and pathology research roundup: September 6 - Insights

This week's research roundup features: Outcomes of tricuspid valve repair with artificial neochordae in pediatric and adult patients

Mayo Clinic Laboratory and pathology research roundup: June 28 - Insights

This week’s research roundup features: Understanding "Patient refuses" among 90+ year old patients with cancer or presumed cancer.

Mayo Clinic Laboratory and pathology research roundup: August 2 - Insights

This week's research roundup features: Gastrointestinal stromal tumors mimicking gynecologic disease: clinicopathological analysis of 20 cases.

Mayo Clinic Laboratory and pathology research roundup: January 25 - Insights

Today's Topic Features: Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib.

Mayo Clinic Laboratory and pathology research roundup: November 15 - Insights

This week's research roundup features: Renin production by juxtaglomerular cell tumors and clear cell renal cell carcinoma and the role of angiotensin signaling inhibitors